Arkolith/Insider Trading/GLSI/Form 4

Patel Snehal

CEO and CFO, Director, 10% OwnerGreenwich LifeSciences, Inc. (GLSI) · full profile →Form 4 · filed Jan 3, 2025
Net Buying
Open-Market Buys
$27K
Open-Market Sells
$0
Net Open-Market Flow
$27K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 31, 2024Buy(P)2K$11.36$27K5.5M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-25-000151) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML